IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
38 hedge funds and large institutions have $2.19M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
38
Holding in Top 10
–
Calls
$2.29M
Puts
–
Top Buyers
| 1 | +$34.5K | |
| 2 | +$25.5K | |
| 3 | +$13.4K | |
| 4 |
CAC
Cowen and Company
New York
|
+$3.5K |
| 5 |
EFI
EHP Funds Inc
Toronto,
Canada
|
+$1.64K |
Top Sellers
| 1 | -$5.35K | |
| 2 | -$1.51K | |
| 3 | -$1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$53 |